NCT06668324Completed
Multiple Sclerosis Patient Experience on Kesimpta and Ocrevus Subcutaneous Formulation
Multiple Sclerosis Patient Experience on Kesimpta and Ocrevus Subcutaneous Formulation (MS-PEKOS)
Source: ClinicalTrials.gov · Last updated 28 Oct 2026
Brief summary (registry, in English)
The study aimed to compare the experiences, including injection-related reactions (IRRs) of patients newly receiving ofatumumab to those starting to receive ocrelizumab SC formulation.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 134 (actual)
- First submitted
- 22 Oct 2024
- Start date
- 15 Nov 2024
- Primary completion date
- 5 Sept 2025
- Lead sponsor
- Novartis Pharmaceuticals
- Diseases
- Multiple sclerosis
- NCT number
- NCT06668324
What you commit to
- Study type: Observational
- Participants enrolled: 134
- From 15 Nov 2024 to the primary completion date, 5 Sept 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Previously treated with OMB or OCR SC
Other illness
- Cognitive impairment that impacts the patient's ability to participate in a survey study
Other
- Participated in an OMB or OCR randomized clinical trial
Who the study is looking for
- Ability to use a mobile device or computer with broadband internet access (or data streaming available)
- Ability to read, understand, and respond in English
- Adult aged 18 years of age or over at the time of the survey
- Self-confirmed diagnosis of MS
- Prescribed either OMB or OCR SC and received their first injection (Day 0) and completed the study survey between Day 1 and Day 7
Age in the registry: 18 years to 99 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| - Coordinator of this site? Confirm its status | East Hanover | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.